EBQ:PEITHO Trial

incomplete Journal Club Article
Meyer G. et al.. "Fibrinolysis for patients with intermediate-risk pulmonary embolism". NEJM. 2014. 10(370):1402-1411.
PubMed Full text PDF

Clinical Question

Does thrombolysis with tenecteplase reduce mortality or hemodynamic collapse in patients with sub-massive PE at 7 days compared to placebo?

Conclusion

  • Fibrinolytic therapy prevented hemodynamic compensation but at the risk of increased hemorrhage and stroke

Major Points

Study Design

Population

Patient Demographics

Inclusion Criteria

Exclusion Criteria

Interventions

Outcomes

Primary Outcome

Secondary Outcomes

Subgroup analysis

Criticisms & Further Discussion

External Links

Funding

Sources

Retrieved from "https://www.wikem.org/w/index.php?title=EBQ:PEITHO_Trial&oldid=23251"